The Effect of Beta-Carotene on Oral Mucositis in Cancer Treatment
Author Information
Author(s): E.E.D. Mills
Primary Institution: National Accelerator Centre and Department of Radiotherapy Tygerberg Hospital and University of Stellenbosch
Hypothesis
Does supplemental dietary beta-carotene modify the progression of oral mucositis during radiation and chemotherapy?
Conclusion
Supplemental beta-carotene resulted in less severe oral mucosal reactions during treatment compared to the control group.
Supporting Evidence
- Patients receiving beta-carotene had significantly less severe oral mucosal reactions.
- 40% of patients achieved complete remission by the end of treatment.
- Long-term follow-up showed sustained local tumor control in some patients.
Takeaway
Giving patients beta-carotene while they get cancer treatment helps their mouths hurt less.
Methodology
Patients were randomized to receive either a standard diet with beta-carotene or a standard diet without it while undergoing radiation and chemotherapy.
Potential Biases
There may be bias due to the small sample size and lack of a placebo group.
Limitations
The small number of patients limits the statistical validity of the results.
Participant Demographics
Twenty patients with advanced squamous carcinoma of the mouth, average age 57 years, all smokers.
Statistical Information
P-Value
<0.025
Statistical Significance
p<0.025
Want to read the original?
Access the complete publication on the publisher's website